Skye Bioscience, Inc. (SKYE) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Skye Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.470 -- 00:00:03.033 Ladies and gentlemen, thank you for standing by. 00:00:03.033 -- 00:00:05.076 My name is Yael, and I will be your conference operator today. 00:00:05.076 -- 00:00:09.442 At this time, I would like to welcome everyone to the Sky Bioscience second quarter 2025 00:00:09.442 -- 00:00:12.526 financial results and business update call. 00:00:12.526 -- 00:00:15.750 All lines have been placed on mute to prevent any background noise. 00:00:15.750 -- 00:00:19.115 After the speaker's remarks, there will be a question and answer session. 00:00:19.115 -- 00:00:23.040 I would now like to turn the conference over to Bernie Hertel, head of investor relations. 00:00:23.040 -- 00:00:23.681 Please go ahead. 00:00:23.681 -- 00:00:27.436 Hello, and thank you all for participating in today's call. 00:00:27.436 -- 00:00:31.360 Before we begin, I'd like to caution that comments made during this conference call will 00:00:31.360 -- 00:00:34.863 contain forward-looking statements under the safe harbor provisions of the U.S. 00:00:34.863 -- 00:00:39.047 Private Securities Litigation Reform Act of 1995, including 00:00:39.047 -- 00:00:43.170 statements about Sky's expectations regarding its development activities, timelines, 00:00:43.170 -- 00:00:44.932 and milestones. 00:00:44.932 -- 00:00:48.535 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:00:48.535 -- 00:00:53.079 results to differ materially and adversely, and reported results should not be considered 00:00:53.079 -- 00:00:57.603 as an indication of future performance. These forward-looking statements speak only as 00:00:57.603 -- 00:01:01.887 of today's date, and the company undertakes no obligation to revise or update any statements 00:01:01.887 -- 00:01:0...